PGEN CFO Buys 11,216 Shares; Beneficial Ownership Rises to 468,626
Insider purchases by Precigen CFO increased his stake in the company.
Rhea-AI Filing Summary
Insider purchases by Precigen CFO increased his stake in the company. Harry Thomasian Jr. acquired 8,284 shares on 09/25/2025 at a weighted average price of $3.62 and 2,932 shares on 09/26/2025 at $3.42, bringing his total beneficial ownership to 468,626 shares. The filing shows the transactions were reported on Form 4 and the price for the 09/25 purchases is a weighted average of trades between $3.53 and $3.67. The report was signed on 09/26/2025 by an attorney-in-fact on behalf of the reporting person.
Positive
- Officer purchases: Chief Financial Officer Harry Thomasian Jr. bought 11,216 shares on 09/25-09/26/2025
- Increased beneficial ownership: Total beneficial ownership rose to 468,626 shares
- Detailed pricing disclosure: 09/25 trades reported with a weighted average price and disclosed price range ($3.53–$3.67)
Negative
- None.
Insights
TL;DR: Company CFO made open-market purchases that modestly increased his stake.
The filing documents direct open-market purchases by the Chief Financial Officer totaling 11,216 shares across two dates, increasing beneficial ownership to 468,626 shares. The 09/25 transaction reports a weighted average price and the filer discloses the price range for those trades. From a disclosure perspective the Form 4 provides the standard level of detail required for Section 16 reporting and includes the attestation signature by an attorney-in-fact.
TL;DR: Transparent reporting of insider transactions with required price-range disclosure.
The report identifies the reporting person as an officer (Chief Financial Officer) and documents purchases made in the open market with a clear footnote on weighted average pricing. The Form 4 includes the reporting person’s address and the required signature. No amendments, dispositions, derivative transactions, or other conditions are disclosed in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,932 | $3.42 | $10K |
| Purchase | Common Stock | 8,284 | $3.62 | $30K |
Footnotes (1)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
FAQ
What insider transactions did PGEN report on this Form 4?
Who filed the Form 4 on behalf of the reporting person?
Does the Form 4 report any derivative transactions or dispositions?
AI-generated analysis. How Rhea-AI works. Not financial advice.